InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,501.77
(
0.49%
)
US TECH 100
19,446.00
(
0.88%
)
Dow Jones
39,299.37
(
0.33%
)
Brent Oil
86.26
(
-0.32%
)
Bitcoin
62,040.25
(
-1.29%
)
Post# of 114067
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

wadegarret

Send PM Follow Ignore
Followers 121
Posts 28753
Boards Moderated 2
Alias Born 10/04/2004

wadegarret

Member Level

Re: None

Friday, 05/03/2024 11:31:45 AM

Friday, May 03, 2024 11:31:45 AM

Post# of 114067
GERN down 10% since Q1 earnings report

Why ? Probably because they had to extend phase 3 for the use of Imetelstat in Myelofibrosis by six months. No biggie IMO, but the market seems to really not like it. I mean the use of Imetelstat for MDS is what GERN is waiting for FDA approval on June 16. I personally think there is still fear that the FDA has it out for GERN, and I decided to lighten up on GERN today in Wadegarret, as it seems negativity has set in, and may remain till June 16
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up